John W Rutland1, Rebecca E Feldman1, Lara V Marcuse2, Madeline C Fields2, Bradley N Delman3, Prantik Kundu 1, and Priti Balchandani1
1Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 2Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 3Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Synopsis
The present study employs
ultra-high field MRI (7 Tesla) to perform structural imaging on a group of 19
epilepsy patients and 9 healthy controls. We use automated segmentation of the
amygdala to derive volumes of constituent sub-nuclei. When comparing epilepsy
patients and controls, we found that the volume of the right lateral nucleus
was reduced compared with controls. We also found that the anterior-amygdaloid-area
and the whole right amygdala approach significance for reduced volume. These
are the first in vivo findings that indicate particular nuclei are affected in
epilepsy patients.
Introduction
The amygdala’s location
in the temporal lobe implicates its role in seizure activity, and the
structure’s role in epilepsy symptomatology is well established [1]. Hippocampal changes in epilepsy have been extensively studied, however
amygdalar alterations are less understood [1,2]. Numerous imaging
studies have found global volume reduction in the amygdala of epilepsy patients [1]. However, because amygdala nuclei have functionally distinct roles, it is also
important to quantify amygdalar changes on a nuclear scale. For example, histopathological
studies have indicated that amygdalar damage from seizure activity may show
nuclear specificity with certain nuclei, such as the lateral nucleus, being
more susceptible than others, like the central nucleus [1,3]. Here we
report the first in vivo findings for nuclei-specific changes that occur in the
amygdala in epilepsy patients.Methods
Nineteen epilepsy patients and 9 healthy controls were
scanned using a 7T whole body scanner (Siemens Magnetom) under an IRB-approved
protocol. The MRI protocol consisting of a T1-weighted MP2RAGE sequence (0.7 mm
isotropic resolution, TE =5.1ms) and a T2-weighted TSE (2mm slice thickness,
coronal oblique with 0.4mmx0.4mm in plane resolution, TE =69ms). Segmentation
of the amygdalar nuclei was perfomed using the development version of
FreeSurfer software [4] version 6.0. Segmentations were obtained using
both T1-weighted MP2RAGE and T2 TSE acquisitions. The amygdala segmentation and
its corresponding look-up table are shown in Figure 1. A two-tailed t-test was
performed on the volumes of amygdalar nuclei in epilepsy patients and healthy
controls. Results
Amygdala
nuclear segmentation revealed that the volume of the right lateral nucleus is
reduced in epilepsy patients (Mean = 585.17 mm3 $$$\pm$$$ 48.81 mm3) compared with healthy controls (Mean
= 658.51 mm3 $$$\pm$$$ 69.45 mm3), p = 0.003. Reduction of volumes
in the right anterior-amygdaloid-area (AAA) and the entire right amygdala approached
significance (p = 0.056 and p = 0.059, respectively). The volumes of the
amygdalal nuclei in patients and controls can be seen in Figure 2. Discussion
This is the first study
to use an automated method to segment the nuclei of the amygdala and perform
volumetric comparison between epilepsy patients and controls. This analysis is
potentially important because of the amygdala’s role in seizure activity [1,2]. Our finding of globally reduced amygdala volume was concordant with
previous findings of reduced amygdala volume.1 However, future work
is required to determine why this effect was not found bilaterally. Interestingly,
histopathological studies have revealed that the lateral nucleus is the most
severely affected nuclei in epilepsy patients [1,3], however this is
the first imaging study to depict this in
vivo. This is significant because not only is the lateral nucleus the major
sensory input to the amygdala, it also has significant projections to other
amygdala nuclei and regions of the cortex. This connectivity confers a central
role in limbic circuitry and seizure propagation [1]. Future work will
validate this study’s findings in a larger cohort, assess changes in amygdala
nuclei volumes in relation to the suspected seizure onset zone, and will
include tractography in order to quantify connectivity changes of amygdalar
sub-regions that exist in epilepsy patients. Acknowledgements
NIH
R00 NS070821
NIH R01 MH109544
Icahn
School of Medicine Capital Campaign
Translational
and Molecular Imaging Institute
References
1.
Pitkänen, A., Tuunanena, J., Kalviainenb, R., Partanenc, K.,
Slamenperab, T. Amygdala damage in experimental and human temporal lobe
epilepsy. Epilepsy Research, vol. 32, no. 1-2, 1998, pp. 233–253.
2.
Goddard, GV.,
McIntyre, DC., Leech, CK. A permanent change in brain function
resulting from daily electrical stimulation. Exp. Neurology, 25
(1969), pp. 295-330.
3. Yilmazer-Hanke, D.
M., Wolf, H. K., Schramm, J., Elger, C. E., Wiestler, O. D., & Blümcke, I. Subregional
Pathology of the Amygdala Complex and Entorhinal Region in Surgical Specimens
From Patients With Pharmacoresistant Temporal Lobe Epilepsy. Journal of Neuropathology & Experimental
Neurology, 2010. 59(10), 907-920.
4.
Saygin ZM & Kliemann D (joint 1st authors), Iglesias JE, van der Kouwe AJW,
Boyd E, Reuter M, Stevens A, Van Leemput K, McKee A, Frosch MP, Fischl B,
Augustinack JC. High-resolution magnetic
resonance imaging reveals nuclei of the human amygdala: manual segmentation to
automatic atlas.
Neuroimage, 155, July 2017, 370-382.